| 000F68 (2007) |
G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède] | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
| 000132 (2011) |
M. Andersson [Suède] ; H. Zetterberg [Suède] ; L. Minthon [Suède] ; K. Blennow [Suède] ; E. Londos [Suède] | The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia |
| 000806 (2010) |
Debby Tsuang ; Eric B. Larson ; Ge Li ; Jane B. Shofer ; Kathleen S. Montine ; Mary Lou Thompson ; Joshua A. Sonnen ; Paul K. Crane ; James B. Leverenz ; Thomas J. Montine | Association Between Lifetime Cigarette Smoking and Lewy Body Accumulation |
| 000A83 (2009) |
Osamu Yokota [Japon] | Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis |
| 000B39 (2009) |
Takashi Haraguchi ; Seishi Terada ; Hideki Ishizu ; Kenichi Sakai ; Yasuyuki Tanabe ; Taiji Nagai ; Hiroshi Takata ; Keigo Nobukuni ; Yuetsu Ihara ; Tetsuyuki Kitamoto [Japon] ; Shigetoshi Kuroda | Coexistence of Creutzfeldt‐Jakob disease, Lewy body disease, and Alzheimer's disease pathology: An autopsy case showing typical clinical features of Creutzfeldt‐Jakob disease |
| 000D47 (2008) |
Rajnish K. Chaturvedi [États-Unis] ; M. Flint Beal [États-Unis] | Mitochondrial Approaches for Neuroprotection |
| 000F96 (2007) |
Mark Lew [États-Unis] | Overview of Parkinson's Disease |
| 001097 (2007) |
M. Kitayama [Japon] ; K. Wada-Isoe [Japon] ; K. Nakaso [Japon] ; Y. Irizawa [Japon] ; K. Nakashima [Japon] | Clinical evaluation of Parkinson’s disease dementia: association with aging and visual hallucination |
| 001441 (2005) |
Louise M. Allan [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] | Prevalence and Severity of Gait Disorders in Alzheimer's and Non‐Alzheimer's Dementias |
| 001586 (2004) |
E. I. Agorogiannis [Grèce] ; G. I. Agorogiannis [Grèce] ; A. Papadimitriou [Grèce] ; G. M. Hadjigeorgiou [Grèce] | Protein misfolding in neurodegenerative diseases |
| 001662 (2004) |
Enrique Noe [États-Unis, Espagne] ; Karen Marder [États-Unis] ; Karen L. Bell [États-Unis] ; Diane M. Jacobs [États-Unis] ; Jennifer J. Manly [États-Unis] ; Yaakov Stern [États-Unis] | Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia |
| 001849 (2002) |
Eliezer Masliah [États-Unis] ; Lawrence A. Hansen [États-Unis] ; Edward Rockenstein [États-Unis] ; Makoto Hashimoto [États-Unis] | Progress in the development of new treatments for combined Alzheimer's and Parkinson's diseases |
| 001925 (2002) |
Lorna Schumann ; Jennifer Hagerty Lingler ; Daniel I. Kaufer | Cognitive and Motor Symptoms in Dementia: Focus on Dementia with Lewy Bodies |
| 001A08 (2001) |
Hitoshi Takahashi ; Koichi Wakabayashi [Japon] | The cellular pathology of Parkinson's disease |
| 001A40 (2001) |
Elaine K. Perry [Royaume-Uni] ; Carmen M. Martin-Ruiz [Royaume-Uni] ; Jennifer A. Court [Royaume-Uni] | Nicotinic receptor subtypes in human brain related to aging and dementia |
| 001D30 (1999) |
David F. Clayton ; Julia M. George | Synucleins in synaptic plasticity and neurodegenerative disorders |
| 001E70 (1998) |
J. William Langston ; Savitha Sastry ; Piu Chan ; Lysia S. Forno ; Laurel M. Bolin ; Donato A. Di Monte | Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease |
| 002207 (1996) |
J. J. Claus [Pays-Bas] ; E. Mohr [Canada] | Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases |
| 002605 (1992) |
L. Lorigados [Suède, Cuba] ; S. Söderström [Suède] ; T. Ebendal [Suède] | Two‐site enzyme immunoassay for βNGF applied to human patient sera |
| 002A10 (1985) |
John P. Blass [États-Unis] ; Laurie L. Barclay [États-Unis] | New developments in the diagnosis of the dementias |
| 000064 (2011-03-15) |
Ana Budimir [Croatie] | Metal ions, Alzheimer's disease and chelation therapy |
| 000133 (2011) |
Brian Jeynes [Canada] ; John Provias [Canada] | The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease |
| 000152 (2011) |
F. Valldeoriola ; C. Coronell [Espagne] ; C. Pont ; M. T. Buongiorno ; A. Cámara ; C. Gaig ; Y. Compta | Socio‐demographic and clinical factors influencing the adherence to treatment in Parkinson’s disease: the ADHESON study |
| 000156 (2011) |
Michael A. Schwarzschild [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Danna Jennings [États-Unis] ; John Seibyl [États-Unis] ; Alberto Ascherio [États-Unis] | Serum urate and probability of dopaminergic deficit in early “Parkinson's disease” |
| 000261 (2011) |
Alisha E. King [États-Unis] ; Jim Mintz [États-Unis] ; Donald R. Royall [États-Unis] | Meta‐analysis of 123I‐MIBG cardiac scintigraphy for the diagnosis of Lewy body–related disorders |
| 000293 (2011) |
D. Okai [Royaume-Uni] ; M. Samuel ; S. Askey-Jones [Royaume-Uni] ; A. S. David [Royaume-Uni] ; R. G. Brown [Royaume-Uni] | Impulse control disorders and dopamine dysregulation in Parkinson’s disease: a broader conceptual framework |
| 000325 (2011) |
Charles. H. Adler [États-Unis] ; Holly A. Shill [États-Unis] ; Thomas G. Beach [États-Unis] | Essential tremor and Parkinson's disease: Lack of a link |
| 000341 (2011) |
E. Mulin [France] ; E. Leone [France] ; K. Dujardin [France] ; M. Delliaux [France] ; A. Leentjens [Pays-Bas] ; F. Nobili [Italie] ; B. Dessi [Italie] ; O. Tible [France] ; L. Agüera-Ortiz [Espagne] ; R. S. Osorio [Espagne] ; J. Yessavage [États-Unis] ; D. Dachevsky [Argentine] ; F. Rj. Verhey [Pays-Bas] ; Alfonso J. Cruz Jentoft [Espagne] ; O. Blanc [France] ; P. M Llorca [France] ; P. H. Robert [France] | Diagnostic criteria for apathy in clinical practice |
| 000343 (2011) |
Friederike Fritze [Norvège] ; Uwe Ehrt [Norvège] ; Hogne S Nnesyn [Norvège] ; Martin Kurz [Norvège] ; Tibor Hortobágyi [Royaume-Uni] ; Sabine Piepenstock Nore [Norvège] ; Clive Ballard [Royaume-Uni] ; Dag Aarsland [Norvège] | Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features |
| 000373 (2011) |
Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Gianni Bellomo [Italie] ; David Giannandrea [Italie] ; Claudia De Carlo [Italie] ; Mohamed M. Qureshi [Émirats arabes unis] ; Mustafa T. Ardah [Émirats arabes unis] ; Shiji Varghese [Émirats arabes unis] ; Laura Bonanni [Italie] ; Barbara Borroni [Italie] ; Nicola Tambasco [Italie] ; Paolo Eusebi [Italie] ; Aroldo Rossi [Italie] ; Marco Onofrj [Italie] ; Alessandro Padovani [Italie] ; Paolo Calabresi [Italie] ; Omar El-Agnaf [Émirats arabes unis] | Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias |
| 000511 (2010) |
Peggy Auinger [États-Unis] ; Karl Kieburtz [États-Unis] ; Michael P. Mcdermott [États-Unis] | The relationship between uric acid levels and Huntington's disease progression |
| 000522 (2010) |
Dylan G. Harwood [États-Unis] ; Ari Kalechstein [États-Unis] ; Warren W. Barker [États-Unis] ; Silvia Strauman [États-Unis] ; Peter St. George-Hyslop [Canada] ; Casandra Iglesias [États-Unis] ; David Loewenstein [États-Unis] ; Ranjan Duara [États-Unis] | The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease |
| 000533 (2010) |
J. S. K. Kauwe [États-Unis] ; S. Bertelsen [États-Unis] ; K. Mayo [États-Unis] ; C. Cruchaga [États-Unis] ; R. Abraham [Royaume-Uni] ; P. Hollingworth [Royaume-Uni] ; D. Harold [Royaume-Uni] ; M. J. Owen [Royaume-Uni] ; J. Williams [Royaume-Uni] ; S. Lovestone [Royaume-Uni] ; J. C. Morris [États-Unis] ; A. M. Goate [États-Unis] | Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease |
| 000592 (2010) |
Joshua A. Sonnen ; Nadia Postupna ; Eric B. Larson ; Paul K. Crane ; Shannon E. Rose ; Kathleen S. Montine ; James B. Leverenz [États-Unis] ; Thomas J. Montine | Pathologic Correlates of Dementia in Individuals with Lewy Body Disease |
| 000644 (2010) |
Elan D. Louis [États-Unis] ; Ming X. Tang [États-Unis] ; Nicole Schupf [États-Unis] | Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population‐based study of elders |
| 000709 (2010) |
Elan D. Louis [États-Unis] | Functional correlates of lower cognitive test scores in essential tremor |
| 000754 (2010) |
Katsuji Kobayashi [Japon] ; Hisashi Sumiya [Japon] ; Hiroyuki Nakano [Japon] ; Noriko Akiyama [Japon] ; Katsumi Urata [Japon] ; Yoshifumi Koshino [Japon] | Detection of Lewy body disease in patients with late‐onset depression, anxiety and psychotic disorder with myocardial meta‐iodobenzylguanidine scintigraphy |
| 000781 (2010) |
Jia-Yi Li [Suède] ; Elisabet Englund [Suède] ; H Kan Widner [Suède] ; Stig Rehncrona [Suède] ; Anders Björklund [Suède] ; Olle Lindvall [Suède] ; Patrik Brundin [Suède] | Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease |
| 000909 (2009) |
Berend Arnold Ploeger [Pays-Bas] ; Nicholas H. G. Holford [Nouvelle-Zélande] | Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysis |
| 000925 (2009) |
Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie] | Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine |
| 000987 (2009) |
Fenna Phibbs [États-Unis] ; John Y. Fang [États-Unis] ; Michael K. Cooper [États-Unis] ; David P. Charles [États-Unis] ; Thomas L. Davis [États-Unis] ; Peter Hedera [États-Unis] | Prevalence of unilateral tremor in autosomal dominant essential tremor |
| 000989 (2009) |
Sebastian Palmqvist [Suède] ; Oskar Hansson [Suède] ; Lennart Minthon [Suède] ; Elisabet Londos [Suède] | Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests |
| 000A13 (2009) |
Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Masaoki Iwanami [Japon] ; Keisuke Suzuki [Japon] ; Yuichi Inoue [Japon] ; Koichi Hirata [Japon] | Odor identification test as an indicator of idiopathic REM sleep behavior disorder |
| 000A59 (2009) |
Anna G Mez [Espagne] ; Isidre Ferrer [Espagne] | Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases |
| 000A64 (2009) |
David J. Brooks [Royaume-Uni] | Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography |
| 000A65 (2009) |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Jacques Y. Montplaisir [Canada] | Idiopathic REM sleep behavior disorder in the transition to degenerative disease |
| 000B53 (2009) |
Helen Petrovitch [États-Unis] ; Robert D. Abbott [États-Unis, Japon] ; G. Webster Ross [États-Unis] ; James Nelson [États-Unis] ; Kamal H. Masaki [États-Unis] ; Caroline M. Tanner [États-Unis] ; Lenore J. Launer [États-Unis] ; Lon R. White [États-Unis] | Bowel movement frequency in late‐life and substantia nigra neuron density at death |
| 000B56 (2009) |
Gráinne C. O Eeffe [Royaume-Uni] ; Andrew W. Michell [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Biomarkers in Huntington's and Parkinson's Disease |
| 000C74 (2008) |
James Scott Miners [Royaume-Uni] ; Shabnam Baig [Royaume-Uni] ; Jennifer Palmer [Royaume-Uni] ; Laura E. Palmer [Royaume-Uni] ; Patrick G. Kehoe [Royaume-Uni] ; Seth Love [Royaume-Uni] | SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ‐Degrading Enzymes in Alzheimer's Disease |
| 000D66 (2008) |
J. Alegre-Abarrategui ; O. Ansorge [Royaume-Uni] ; M. Esiri [Royaume-Uni] ; R. Wade-Martins | LRRK2 is a component of granular alpha‐synuclein pathology in the brainstem of Parkinson's disease |
| 000D73 (2008) |
Andrew B. Knott [États-Unis] ; Ella Bossy-Wetzel [États-Unis] | Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration |
| 000D77 (2008) |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study |
| 000E01 (2008) |
Yvette A. M. Grimbergen [Pays-Bas] ; Mirjam J. Knol [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; Berry P. H. Kremer [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas] ; Marten Munneke [Pays-Bas] | Falls and gait disturbances in Huntington's disease |
| 000E21 (2008) |
Li [République populaire de Chine] ; Clifford R. Jack [États-Unis] ; Xi-Fei Yang [République populaire de Chine] ; Edward S. Yang [République populaire de Chine] | Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: An in vivo volume MRI study |
| 000E77 (2008) |
Urs Peter Mosimann [Royaume-Uni] ; Daniel Collerton [Royaume-Uni] ; Robert Dudley [Royaume-Uni] ; Thomas Daniel Meyer [Royaume-Uni] ; Gemma Graham [Royaume-Uni] ; Jennifer Louise Dean [Royaume-Uni] ; Daniel Bearn [Royaume-Uni] ; Alison Killen [Royaume-Uni] ; Lucy Dickinson [Royaume-Uni] ; Mike Patrick Clarke [Royaume-Uni] ; Ian Grant Mckeith [Royaume-Uni] | A semi‐structured interview to assess visual hallucinations in older people |
| 000F40 (2007) |
Koichi Wakabayashi ; Kunikazu Tanji ; Fumiaki Mori ; Hitoshi Takahashi [Japon] | The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates |
| 000F46 (2007) |
Takeshi Iwatsubo [Japon] | THIS ARTICLE HAS BEEN RETRACTED: Pathological biochemistry of α‐synucleinopathy |
| 000F49 (2007) |
Frauke Boddy [Royaume-Uni] ; Elise N. Rowan [Royaume-Uni] ; Debbie Lett [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease |
| 000F57 (2007) |
Margaret A. Piggott [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; Elise Rowan [Royaume-Uni] ; Clive Holmes [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; Evelyn Jaros [Royaume-Uni] ; Robert H. Perry [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline |
| 001036 (2007) |
Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Moussa B. H. Youdim [Israël] | Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil |
| 001076 (2007) |
Bernard Ravina [États-Unis] ; Karen Marder [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Joseph H. Friedman [États-Unis] ; William Mcdonald [États-Unis] ; Diane Murphy [États-Unis] ; Dag Aarsland [États-Unis] ; Debra Babcock [États-Unis] ; Jefferey Cummings [États-Unis] ; Jean Endicott [États-Unis] ; Stewart Factor [États-Unis] ; Wendy Galpern [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Laura Marsh [États-Unis] ; Mark Stacy [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Valerie Voon [États-Unis] ; Christopher Goetz [États-Unis] | Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group |
| 001098 (2007) |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
| 001127 (2007) |
Eduardo Tolosa [Espagne] ; Thierry Vander Borght [Belgique] ; Emilio Moreno [Espagne] | Accuracy of DaTSCAN (123I‐ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2‐Year follow‐up of an open‐label study |
| 001133 (2007) |
Leung Wing Chu [Hong Kong] ; Yan Li [Hong Kong] ; Zhong Li [Hong Kong, République populaire de Chine] ; Alan Yb Tang [Hong Kong] ; Bernard My Cheung [Hong Kong] ; Raymond Yh Leung [Hong Kong] ; Ping-Yiu Yik [Hong Kong] ; Dong-Yan Jin [Hong Kong] ; You-Qiang Song [Hong Kong] | A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese |
| 001162 (2006) |
Pietro Tiraboschi ; David P. Salmon ; Lawrence A. Hansen ; Richard C. Hofstetter ; Leon J. Thal ; Jody Corey-Bloom | What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? |
| 001218 (2006) |
Laura Marsh [États-Unis] ; William M. Mcdonald [États-Unis] ; Jeffrey Cummings [États-Unis] ; Bernard Ravina [États-Unis] | Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group |
| 001239 (2006) |
François Sellal [France] | Parkinson's disease with dementia and dementia with Lewy body disease: two syndromes, the same disease? |
| 001248 (2006) |
Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Robert A. Hauser [États-Unis] ; Juan Sanchez-Ramos [États-Unis] | Open‐label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease |
| 001281 (2006) |
A. Cagnin [Italie] ; M. Kassiou [Australie] ; S. R. Meikle [Australie] ; R. B. Banati [Australie] | In vivo evidence for microglial activation in neurodegenerative dementia |
| 001320 (2006) |
Klaus Seppi [Autriche] ; Michael F. H. Schocke [Autriche] ; Katherina J. Mair [Autriche] ; Regina Esterhammer [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Barbara Utermann [Autriche] ; Karl Egger [Autriche] ; Christian Brenneis [Autriche] ; Roberta Granata [Autriche] ; Sylvia Boesch [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Diffusion‐weighted imaging in Huntington's disease |
| 001334 (2006) |
Lawrence S. Mayer [États-Unis] ; R. Curt Bay [États-Unis] ; Antonios Politis [États-Unis] ; Martin Steinberg [États-Unis] ; Cynthia Steele [États-Unis] ; Alva S. Baker [États-Unis] ; Peter V. Rabins [États-Unis] ; Constantine G. Lyketsos [États-Unis] | Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS |
| 001363 (2006) |
Giuseppina Candore [Italie] ; Carmela R. Balistreri [Italie] ; Maria P. Grimaldi [Italie] ; Sonya Vasto [Italie] ; Florinda Listì [Italie] ; Martina Chiappelli [Italie] ; Federico Licastro [Italie] ; Domenico Lio [Italie] ; Calogero Caruso [Italie] | Age‐Related Inflammatory Diseases |
| 001426 (2005) |
Urs P. Mosimann ; Rene M. Mu Ri ; David J. Burn ; Jacques Felblinger [France] ; John T. O'Brien ; Ian G. Mckeith | Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies |
| 001431 (2005) |
Ashwini K. Rao [États-Unis] ; Lori Quinn [États-Unis] ; Karen S. Marder [États-Unis] | Reliability of spatiotemporal gait outcome measures in Huntington's disease |
| 001479 (2005) |
Masayuki Sugie [Japon] ; Jun Goto [Japon] ; Mitsuru Kawamura ; Hidekazu Ota [Japon] | Increased norepinephrine‐associated adrenomedullary inclusions in Parkinson's disease |
| 001483 (2005) |
Felix Geser [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] ; Ian Mckeith [Royaume-Uni] | How to diagnose dementia with Lewy bodies: State of the art |
| 001528 (2005) |
S. Papapetropoulos [États-Unis] ; A. Lieberman [États-Unis] ; J. Gonzalez [États-Unis] ; D. C. Mash [États-Unis] | Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease? |
| 001589 (2004) |
Francesca Cormack [Royaume-Uni] ; Dag Aarsland [Norvège] ; Clive Ballard [Royaume-Uni] ; Martin J. Tovée [Royaume-Uni] | Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia |
| 001596 (2004) |
M. Desmurget ; V. Gaveau ; P. Vindras ; R. S. Turner ; E. Broussolle [États-Unis] ; S. Thobois [États-Unis] | On-line motor control in patients with Parkinson's disease |
| 001611 (2004) |
Yume Okada [Japon] ; Yuji Ito ; Junko Aida ; Masahiro Yasuhara ; Shin-Ichiro Ohkawa ; Katsuiku Hirokawa [Japon] | Lewy bodies in the sinoatrial nodal ganglion: Clinicopathological studies |
| 001619 (2004) |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Inflammation and the Degenerative Diseases of Aging |
| 001668 (2004) |
A. W. Michell [Royaume-Uni] ; S. J. G. Lewis [Royaume-Uni] ; T. Foltynie [Royaume-Uni] ; R. A. Barker [Royaume-Uni] | Biomarkers and Parkinson's disease |
| 001698 (2003) |
Sudeep S. Gill [Canada] ; Paula A. Rochon [Canada] ; Mark Guttman [Canada] ; Andreas Laupacis | The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia |
| 001713 (2003) |
Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Role of dopamine transporter imaging in routine clinical practice |
| 001728 (2003) |
Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis] | Parkinson's disease is associated with hippocampal atrophy |
| 001734 (2003) |
Christopher Hawkes [Royaume-Uni] | Olfaction in neurodegenerative disorder |
| 001789 (2003) |
Stanley Fahn [États-Unis] | Description of Parkinson's Disease as a Clinical Syndrome |
| 001828 (2002) |
P. H. Robert [France] ; S. Clairet [France] ; M. Benoit [France] ; J. Koutaich [France] ; C. Bertogliati [France] ; O. Tible [France] ; H. Caci [France] ; M. Borg [France] ; P. Brocker [France] ; P. Bedoucha [France] | The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment |
| 001847 (2002) |
Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery R. Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada] | Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases |
| 001859 (2002) |
Kuniaki Tsuchiya ; Kenji Ikeda ; Kazuhiro Niizato ; Sadakiyo Watabiki ; Midori Anno ; Kazuhiro Taki [Japon] ; Chie Haga ; Shuji Iritani ; Masaaki Matsushita | Parkinson’s disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases |
| 001868 (2002) |
Jaeseung Jeong [Corée du Sud] | Nonlinear dynamics of EEG in Alzheimer's disease |
| 001927 (2002) |
James H. Bower [États-Unis] ; Dennis W. Dickson [États-Unis] ; Laura Taylor [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis] | Clinical correlates of the pathology underlying parkinsonism: A population perspective |
| 001989 (2001) |
Yasushi Arai [Japon] ; Mineo Yamazaki [Japon] ; Osamu Mori [Japon] ; Hiromi Muramatsu [Japon] ; Goro Asano [Japon] ; Yasuo Katayama [Japon] | α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation |
| 001A02 (2001) |
M C Parkinson ; S J Harland ; P. Harnden ; A. Sandison [Royaume-Uni] | The role of the histopathologist in the management of testicular germ cell tumour in adults |
| 001A38 (2001) |
Barkur S. Shastry [États-Unis] | Parkinson disease: etiology, pathogenesis and future of gene therapy |
| 001A45 (2001) |
Luc P. De Vreese [Italie] ; Mirco Neri [Italie] ; Mario Fioravanti [Italie] ; Luciano Belloi [Italie] ; Orazio Zanetti [Italie] | Memory rehabilitation in Alzheimer's disease: a review of progress |
| 001A90 (2001) |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 001B12 (2001) |
Michael K. Lee [États-Unis] ; Donald L. Price [États-Unis] | Advances in genetic models of Parkinson's disease |
| 001B50 (2000) |
K. Ancolio [France] ; C. Alves Da Costa [France] ; K. Uéda [Japon] ; F. Checler [France] | α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells |
| 001B71 (2000) |
A.-C. Bachoud-Lévi [France] ; C. Bourdet [France] ; P. Brugières [France] ; J.-P. Nguyen [France] ; T. Grandmougin [France] ; B. Haddad [France] ; R. Jény [France] ; P. Bartolomeo [France] ; M.-F. Boissé [France] ; G. Dalla Barba [France] ; J.-D. Degos [France] ; A.-M. Ergis [France] ; J.-P. Lefaucheur [France] ; F. Lisovoski [France] ; E. Pailhous [France] ; P. Rémy [France] ; S. Palfi [France] ; G. L. Defer [France] ; P. Cesaro [France] ; P. Hantraye [France] ; M. Peschanski [France] | Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease |
